Skip to main content

Table 3 Patient baseline demographic and clinical characteristics

From: Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

Characteristic n = 60
Female, n (%) 52 (86.7%)
White, n (%) 60 (100%)
Age, mean (SD), years 43.5 (10.7)
BMI, mean (SD), kg/m2 30.8 (7.9)
Duration of current MDD episode, mean (SD), months a 18.9 (20.2)
Other psychiatric history, n (%) 42 (70.0%)
MADRS score, n (%)  
   13 - 20 15 (25.0%)
   21 - 25 14 (23.3%)
   26 - 30 19 (31.7%)
   ≥31 12 (20.0%)
MADRS score, mean (SD) 25.7 (6.31)
CGI-S score, n (%)  
   3 - Mildly ill 1 (1.7%)
   4 - Moderately ill 32 (53.3%)
   5 - Markedly ill 22 (36.7%)
   6 - Severely ill 5 (8.3%)
   7 - Among the most extremely ill patients 0 (0.0%)
  1. a n = 59